Beta Drugs (India) Today
| BETA Stock | 1,810 54.15 3.08% |
PerformanceVery Weak
|
Beta Drugs is selling for under 1809.95 as of the 19th of March 2025; that is 3.08% up since the beginning of the trading day. The stock's lowest day price was 1758.0. Beta Drugs has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Beta Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Beta Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Beta Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs (View all Sectors) |
Beta Drugs (BETA) is traded on National Stock Exchange of India in India .
Check Beta Drugs Probability Of Bankruptcy
Beta Drugs Risk Profiles
Although Beta Drugs' alpha and beta are two of the key measurements used to evaluate Beta Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.85 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.92 | |||
| Risk Adjusted Performance | (0.06) |
Beta Drugs Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Beta Drugs Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Beta Drugs price patterns.
Beta Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beta Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.